Evidence map›Paper›PMID 41034490›Full record

ArticleCommunications biology2025

Photosensitizer-specific bacterial stress responses in Escherichia coli reveal distinct targets in photoinduced inactivation.

Marco Chittò, David Tutschner, Ulrich Dobrindt, Anzhela Galstyan, Michael Berger

Abstract read
In one paragraph

Article in Communications biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Marco ChittòInstitute of Hygiene, University of Münster, Münster, Germany.
David TutschnerInstitute of Hygiene, University of Münster, Münster, Germany.
Ulrich DobrindtInstitute of Hygiene, University of Münster, Münster, Germany.ORCID http://orcid.org/0000-0001-9949-1898
Anzhela GalstyanUniversity of Duisburg-Essen, Faculty of Chemistry, Center for Nanointegration Duisburg Essen (CENIDE), Center for Water and Environmental Research (ZWU) and Center for Molecular Biotechnology (ZMB), Universitätsstrasse 5, Essen, Germany. anzhela.galstyan@uni-due.de.ORCID http://orcid.org/0000-0003-0309-1078
Michael BergerInstitute of Hygiene, University of Münster, Münster, Germany. Michael.Berger@ukmuenster.de.ORCID http://orcid.org/0000-0002-6480-1494

Funding

Deutsche Forschungsgemeinschaft (German Research Foundation) GA 2362/6-1
6 · The paper itself

Abstract

The ongoing antibiotic crisis calls for alternative antimicrobial strategies. Antimicrobial photodynamic therapy (aPDT) offers a sustainable option, employing a light-activated photosensitizer (PS) to generate cytotoxic reactive oxygen species (ROS). The non-selective nature of these ROS helps minimize the risk of resistance development. Despite the development of numerous PSs, limited data on their exact mechanisms and bacterial targets still hinders broader clinical use. The focus of this study is to address this gap by capturing pathway-specific responses to sub-lethal photodynamic stress using a panel of transcriptional biosensors in E. coli K-12 strain MG1655. Our results indicate that methylene blue (MB) primarily causes oxidative stress in the cytosol while silicon phthalocyanine derivative (SiPc) induces envelope stress at physiological conditions. By monitoring well-characterized stress response pathways, our method offers a valuable tool for elucidating the physiological effects of aPDT and guiding more detailed mechanistic or transcriptomic studies.

Indexed as

Escherichia coliEscherichia coli K12Photosensitizing AgentsStress, PhysiologicalGene Expression Regulation, BacterialIndolesLightMethylene BlueOxidative StressPhotochemotherapyReactive Oxygen SpeciesIndolesMethylene BluePhotosensitizing AgentsReactive Oxygen Species

Identifiers

PMID41034490
PMCPMC12488859

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.